John H Durham
Author pages are created from data sourced from our academic publisher partnerships and public sources.
N-acetylcysteine in the prevention of radiocontrast-induced nephropathy.
- S. Fishbane, J. H. Durham, K. Marzo, M. Rudnick
- Journal of the American Society of Nephrology…
- 1 February 2004
N-acetylcysteine is a remarkably active agent shown to be useful in a variety of clinical settings. The drug has actions relevant to radiocontrast-induced nephropathy (RCIN) that include… Expand
Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (FG-4592) for the Treatment of Anemia in Patients with CKD.
- Robert Provenzano, A. Besarab, +13 authors Thomas B. Neff
- Clinical journal of the American Society of…
- 6 June 2016
BACKGROUND AND OBJECTIVES Roxadustat (FG-4592), an oral hypoxia-inducible factor prolyl hydroxylase inhibitor that stimulates erythropoiesis, regulates iron metabolism, and reduces hepcidin, was… Expand
Renal salt wasting without cerebral disease: diagnostic value of urate determinations in hyponatremia.
- J. Maesaka, N. Miyawaki, T. Palaia, S. Fishbane, J. H. Durham
- Kidney international
- 2 April 2007
CASE PRESENTATION A 76-year-old woman, who sustained an accidental fracture of the femoral neck, developed hyponatremia after admission. The diagnosis of the syndrome of inappropriate secretion of… Expand
Treating Interdialytic Hyperkalemia with Fludrocortisone
Hyperkalemia is a frequent and dangerous problem in dialysis patients. Many factors contribute to potentially life‐threatening potassium elevation and most remedies used to treat hyperkalemia are… Expand